Diane Mellett

Director/Board Member at CIRCIO HOLDING ASA

66 year

Health Technology

Profile

Ms. Diane Mellett is an Independent Director at Circio Holding ASA. She is on the Board of Directors at Circio Holding ASA. Ms. Mellett was previously employed as a Chief Business Officer & General Counsel by Affitech A/S and a General Counsel by Cambridge Antibody Technology Ltd. She also served on the board at BioXpress Therapeutics SA.

Diane Mellett active positions

Companies	Position	Start
CIRCIO HOLDING ASA	Director/Board Member	2015-09-13

All active positions of Diane Mellett

Former positions of Diane Mellett

Companies	Position	End
MedImmune Ltd. MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies	General Counsel	2006-06-29
BioXpress Therapeutics SA BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity	Director/Board Member	-
Affitech A/S Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics	Director/Board Member	2010-05-26

See the detail of Diane Mellett's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Diane Mellett's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
MedImmune Ltd. MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies	Health Technology
Affitech A/S Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics	Health Technology
Circio Holding ASA Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines	Health Technology
BioXpress Therapeutics SA BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity	Health Technology